当前位置: X-MOL 学术Transpl. Immunol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
A patient with end-stage renal disease who recovered from coronavirus disease 2019 then received a kidney transplant
Transplant Immunology ( IF 1.6 ) Pub Date : 2021-04-22 , DOI: 10.1016/j.trim.2021.101395
Tianyu Wang 1 , Tao Qiu 1 , Ming Wang 2 , Yan Yuan 3 , Zhongbao Chen 1 , Xiaoxiong Ma 1 , Long Zhang 1 , Jilin Zou 1 , Zeya Jin 1 , Yu Xu 1 , Yalong Zhang 1 , Jiangqiao Zhou 1
Affiliation  

Since its emergence in December 2019 many end-stage renal disease (ESRD) patients have been infected with coronavirus disease 2019 (COVID-19). Herein, we describe the case of an ESRD patient who received a kidney transplant after recovering from COVID-19. We described the clinical course of COVID-19 and kidney transplant management, including the patient's symptoms, laboratory results, computed tomography, and antibody profiles. He recovered well, without complications. Chest computed tomography, PCR, and IgG results indicated no recurrence of COVID-19 during the subsequent two weeks. Therefore, kidney transplantation is feasible in an ESRD patient who has recovered from COVID-19, under a normal immunosuppressive regimen.



中文翻译:

一名从 2019 冠状病毒病中康复的终末期肾病患者随后接受了肾移植

自 2019 年 12 月出现以来,许多终末期肾病 (ESRD) 患者已感染 2019 冠状病毒病 (COVID-19)。在此,我们描述了一名从 COVID-19 康复后接受肾脏移植的 ESRD 患者的案例。我们描述了 COVID-19 的临床过程和肾移植管理,包括患者的症状、实验室结果、计算机断层扫描和抗体概况。他恢复得很好,没有并发症。胸部计算机断层扫描、PCR 和 IgG 结果表明,在随后的两周内,COVID-19 没有复发。因此,在正常的免疫抑制方案下,肾移植对于 COVID-19 康复的 ESRD 患者是可行的。

更新日期:2021-05-11
down
wechat
bug